Department of Computer Science, Therapeutic Sciences, Trier University of Applied Sciences, Trier, Germany.
Physio Meets Science, Leimen, Germany.
PLoS One. 2022 Jul 1;17(7):e0269694. doi: 10.1371/journal.pone.0269694. eCollection 2022.
The STarT-MSK-Tool is an adaptation of the well established STarT-Back-Tool, used to risk-stratify patients with a wider range of musculoskeletal presentations.
To formally translate and cross-culturally adapt the Keele STarT-MSK risk stratification tool into German (STarT-MSKG) and to establish its reliability and validity.
A formal, multi-step, forward and backward translation approach was used. To assess validity patients aged ≥18 years, with acute, subacute or chronic musculoskeletal presentations in the lumbar spine, hip, knee, shoulder, or neck were included. The prospective cohort was used with initial data collected electronically at the point-of-consultation. Retest and 6-month follow-up questionnaires were sent by email. Test-retest reliability, construct validity, discriminative ability, predictive ability and floor or ceiling effects were analysed using intraclass correlation coefficient, and comparisons with a reference standard (Orebro-Musculoskeletal-Pain-Questionnaire: OMPQ) using correlations, ROC-curves and regression models.
The participants' (n = 287) mean age was 47 (SD = 15.8) years, 51% were female, with 48.8% at low, 43.6% at medium, and 7.7% at high risk. With ICC = 0.75 (95% CI 0.69; 0.81) test-retest-reliability was good. Construct validity was good with correlations for the STarT-MSKG-Tool against the OMPQ-Tool of rs = 0.74 (95% CI 0.68, 0.79). The ability of the tool [comparison OMPQ] to predict 6-month pain and disability was acceptable with AUC = 0.77 (95% CI 0.71, 0.83) [OMPQ = 0.74] and 0.76 (95% CI 0.69, 0.82) [OMPQ = 0.72] respectively. However, the explained variance (linear/logistic regression) for predicting 6-month pain (21% [OMPQ = 17%]/logistic = 29%) and disability (linear = 20%:[OMPQ = 19%]/logistic = 26%), whilst being comparable to the existing OMPQ reference standard, fell short of the a priori target of ≥30%.
The German version of the STarT-MSK-Tool is a valid instrument for use across multiple musculoskeletal conditions and is availabe for use in clinical practice. Comparison with the OMPQ suggests it is a good alternative.
STarT-MSK-Tool 是经过充分验证的 STarT-Back-Tool 的改编版,用于对更广泛的肌肉骨骼表现的患者进行风险分层。
将基尔的 Keele STarT-MSK 风险分层工具正式翻译成德语(STarT-MSKG),并确定其可靠性和有效性。
采用正式的、多步骤的向前和向后翻译方法。为了评估有效性,纳入了年龄≥18 岁、具有急性、亚急性或慢性肌肉骨骼表现的腰椎、臀部、膝盖、肩部或颈部的患者。前瞻性队列研究采用电子方式在就诊时收集初始数据。通过电子邮件发送了重新测试和 6 个月随访问卷。使用组内相关系数分析重测信度、结构效度、判别能力、预测能力和地板或天花板效应,并与参考标准(Orebro-Musculoskeletal-Pain-Questionnaire:OMPQ)进行比较,使用相关性、ROC 曲线和回归模型。
研究纳入了 287 名参与者,他们的平均年龄为 47(SD=15.8)岁,51%为女性,低风险者占 48.8%,中风险者占 43.6%,高风险者占 7.7%。STarT-MSKG 工具的重测信度良好,ICC 值为 0.75(95%CI 0.69;0.81)。与 OMPQ-Tool 的相关性 rs 值为 0.74(95%CI 0.68,0.79),STarT-MSKG 工具的结构效度良好。工具(与 OMPQ 比较)预测 6 个月疼痛和残疾的能力尚可,AUC 值分别为 0.77(95%CI 0.71,0.83)[OMPQ=0.74]和 0.76(95%CI 0.69,0.82)[OMPQ=0.72]。然而,预测 6 个月疼痛(线性/逻辑回归:21%[OMPQ=17%]/逻辑=29%)和残疾(线性=20%:[OMPQ=19%]/逻辑=26%)的方差解释率(线性/逻辑回归)虽然与现有的 OMPQ 参考标准相当,但仍低于事先设定的≥30%的目标。
STarT-MSK 工具的德语版本是一种适用于多种肌肉骨骼疾病的有效工具,可在临床实践中使用。与 OMPQ 的比较表明,它是一个很好的替代工具。